14
Rehabilitation is a major component of health sciences, and is the process of restoring an incapacitated individual to a normal life through training and therapy. Globally, 2.4 billion people may currently require rehabilitation. In 60 to 70% of countries, existing rehabilitation services have been disrupted due to the coronavirus disease 2019 (COVID-19) pandemic. Even after lockdowns and with vaccinations, some form of physical distancing is likely to be part of the new normal. Concurrently, there is an exponential growth of telehealth. This global overview will demonstrate that telerehabilitation (TR) is likely to be a distinct stand-alone sub-specialty of telehealth. Details of setting up TR, methods, and components are discussed, and clinical indications, limitations, advantages, disadvantages, challenges, and barriers to implementation and technological advances in TR are highlighted followed by an in-depth study of the literature from India.
60Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19
40Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19
Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19
2Perioperative Cardiac Research Considerations During the Coronavirus Disease 2019 (COVID-19) Pandemic
Perioperative Cardiac Research Considerations During the Coronavirus Disease 2019 (COVID-19) Pandemic
34COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.
COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.
22Implications of the COVID-19 Pandemic for Pediatric Primary Care Practice in Europe
Implications of the COVID-19 Pandemic for Pediatric Primary Care Practice in Europe
20Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.
Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e346–e380.
291Sharpening the global focus on ethnicity and race in the time of COVID-19
Sharpening the global focus on ethnicity and race in the time of COVID-19
3COVID-19 and the Kidney Community: Coalescing in Crisis
COVID-19 and the Kidney Community: Coalescing in Crisis
74Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment
Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment
Read more15Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
43COVID-19 in endoscopy: Time to do more?
COVID-19 in endoscopy: Time to do more?
7The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
51The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors
The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors
Read more54Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists
The SARS-CoV-2 pandemic and covid-19 diffusion are an international public health emergency.1 Cancer patients are particularly exposed to infections and their potential complications.2 In this context, the usual clinical decision-making process in radiation therapy is being consistently revised.3 There is an urgent need to share expertise and offer emergency guidance. It is crucial to minimise contacts and to reduce the complexity of radiation treatments where possible to optimise the workforce, keeping intact the effectiveness of the interventions.4 Radiation and systemic therapy modifications should be implemented depending on local circumstances.5 A general guiding principle should include approaches where clinical equivalence supported by trials testing de-escalation strategies is present even without level 1–2 evidence (box 1, bullet points 1).3 Patients with cancer have an intrinsic degree of frailty and therefore are prone to covid-19 complications. Age and comorbidities have been reported as independent risk factors for poor outcome during covid-19 infection and, of note, more than half of cancer patients are elderly and have significant comorbidities (box 1, bullet points 2).6 Hence, an appropriate evaluation of the risk-benefit of radiation therapy treatments is cogent. Urgent cases and non-deferrable treatments (ie, active tumours, spinal cord compression, life threatening bleeding) should be initiated or continued, provided there is full compliance with the safety regulations of local authorities for both patients and staff members. In non-urgent cases, irradiation can be postponed to an extent, depending on the clinical setting and the possibility to offer patients bridging systemic therapies. Whenever radiation therapy is indicated, dose prescription, fractionation and delivery techniques should be adapted, reduced in duration, and optimised (box 1, bullet points 3 and 4). A timely example of precision medicine application is non-metastatic breast cancer radiation …
Read more201Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
Read more
Copyright 2026 Cactus Communications. All rights reserved.
